Patent · US Active

Anti-HER antibodies

US9327035B2 · kind B2 · utility

7Cited by
23References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2013
Grant dateMay 3, 2016
Priority date
Expiry dateOct 29, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-HER antibodies, including multispecific anti-HER antibodies, compositions comprising and methods of using these antibodies. Also provided herein are EGFR/HER3 multispecific antibodies that are less toxic than traditional EGFR antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.